C
Cytek
Biotech & Life Sciences · Fremont, United States · Founded 1992 · IPO 2021
A leading manufacturer and supplier of flow cytometry products and services MoreLess
Cytek Biosciences is a cell analysis solutions company that provides instruments, software, and services to the life sciences sector. The company's core technology is its proprietary Full Spectrum Profiling™ (FSP™), which is integrated into its flow cytometry instruments. These systems are designed to provide high-resolution and high-content cell analysis, enabling researchers and clinicians to obtain deeper insights from a single sample.
The company's product portfolio includes the Aurora and Northern Lights systems, which are full spectrum flow cytometers, and the Cytek Aurora CS, a cell sorter. To support its hardware, Cytek offers software for panel design and data analysis, such as the SpectroFlo® software and the Cytek Cloud platform. Its business model revolves around the sale of these instruments and related reagents, as well as providing technical support and training services.
Cytek serves a global market, with customers in academic research institutions, pharmaceutical and biotechnology companies, and clinical research organizations. The company is focused on applications in immunology, oncology, and cell biology, aiming to advance research in these fields.
Keywords: cell analysis, flow cytometry, biotechnology, life sciences, medical devices, diagnostics, immunology, oncology, reagents, scientific instruments
Talent graph
Cytek's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Cytek has talent and traffic
team presence
across markets
Patent intelligence
Cytek’s patent portfolio
116 active families in the valuation dataset.
Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.
Market sentiment
What the market is saying about Cytek
An AI-synthesized read of the highest-engagement posts about Cytek on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cytek on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.






